Showing 4221-4230 of 5623 results for "".
- Skye Bioscience Reports Potential Neuroprotective Benefit of SBI-100 In Preclinical Glaucoma Modelhttps://modernod.com/news/skye-bioscience-reports-potential-neuroprotective-benefit-of-sbi-100-in-preclinical-glaucoma-model/2480611/Skye Bioscience announced that in a preclinical study assessing the neuroprotective properties of its SBI-100 ophthalmic nanoemulsion, the treated group demonstrated a trend of retaining greater function of the eye’s retinal ganglion cells (RGCs) versus vehicle control. RGCs are cells
- Hubble Lenses Fined Millions After Settling Charges it Violated the Contact Lens Rule and FTC Act to Boost Saleshttps://modernod.com/news/hubble-lenses-fined-millions-after-settling-charges-it-violated-the-contact-lens-rule-and-ftc-act-to-boost-sales/2480604/New York City-based Vision Path, the online seller of direct-to-consumer Hubble lenses, will pay penalties and redress totaling $3.5 million to settle Federal Trade Commission (FTC) charges that it violated the Contact Lens Rule in several ways, including by failing to obtain prescriptions and to
- FDA Approves Genentech’s Vabysmo, the First Bispecific Antibody for the Eye, to Treat Wet AMD and DMEhttps://modernod.com/news/fda-approves-genentechs-vabysmo-the-first-bispecific-antibody-for-the-eye-to-treat-wet-amd-and-dme/2480603/The FDA has approved Genentech's Vabysmo (faricimab-svoa) for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME), marking the first bispecific antibody approved for the eye. Vabysmo is also the first and only FDA-approved inj
- Nanodropper and Lumata Health Launch Partnership Aimed at Improving Patient Carehttps://modernod.com/news/nanodropper-and-lumata-health-launch-partnership-aimed-at-improving-patient-care/2480600/Nanodropper recently announced a partnership with Lumata Health, which includes the launch of a pilot program bringing the Nanodropper Adaptor device to Lumata Health network patients across the United States. Lumata Health is a tech-enabled health care service company fo
- Kriya Licenses Next Generation Complement-Targeted Gene Therapies for the Treatment of Geographic Atrophy and Other Ocular Diseaseshttps://modernod.com/news/kriya-licenses-next-generation-complement-targeted-gene-therapies-for-the-treatment-of-geographic-atrophy-and-other-ocular-diseases/2480593/Kriya Therapeutics announced an exclusive agreement with the Medical University of South Carolina (MUSC) Foundation for Research Development to license next generation complement-targeted gene therapies for the treatment of geographic atrophy and other ocular diseases. "This partne
- Using Cryo-Electron Tomography, UCI Researchers Reveal Molecular Mechanisms Underlying Mutations Within the Eye that Lead to Blindnesshttps://modernod.com/news/uc-irvine-researchers-reveal-molecular-mechanisms-of-eye-disease-using-cryo-electron-tomography/2480586/For the first time, University of California, Irvine researchers in collaboration with the Max-Planck Institute of Biochemistry, have revealed, at a molecular level, key structural determinants of the highly specialized rod outer segment (ROS) membrane architecture of the eye, which is instrument
- 2022 President Robert E. Wiggins Jr., MD, MPH Takes the Academy’s Reinshttps://modernod.com/news/2022-president-robert-e-wiggins-jr-md-mph-takes-the-academys-reins/2480585/Medicine is a constantly developing industry—just ask 2022 Academy President Robert E. Wiggins Jr., MD, MPH. When his practice was acquired in the 1990s, Dr. Wiggins returned to school and obtained a masters degree in health care administration, turning Asheville Eye Associa
- More than 240 Exhibitors Commit to Vision Expo East 2022, Taking Place In-Person from March 31–April 3 at the Javits Centerhttps://modernod.com/news/more-than-240-exhibitors-commit-to-vision-expo-east-2022-taking-place-in-person-from-march-31-april-3-at-the-javits-center/2480582/The organizers of Vision Expo, The Vision Council and RX, share that more than 240 exhibitors have committed to Vision Expo East to-date. Vision Expo East 2022 will take place from March 31–April 3 at the Jacob Javits Center in New York City. &l
- Euclid Systems Launches MyEuclid Customer Portalhttps://modernod.com/news/euclid-systems-launches-myeuclid-customer-portal/2480579/Euclid Systems announced an initial launch of MyEuclid, a new interactive, web-based customer portal designed to help drive practice efficiency and optimize Euclid Ortho-K fits. Used on millions of eyes a
- Avellino Enters Into Distribution Agreement With Keeler to Sell Genetic Eye Test AvaGenhttps://modernod.com/news/avellino-enters-into-distribution-agreement-with-keeler-to-sell-genetic-eye-test-avagen/2480576/Avellino Lab USA and Keeler have entered into an agreement where Keeler will distribute AvaGen on its US website. Terms of the deal were not disclosed. AvaGen is the first genetic test that helps determine a patient’s risk of keratoconus and the presence